New Guidance on GLP-1 Use Before Surgery

Recent guidelines from several medical societies, including the American Society of Anesthesiologists and the American Gastroenterological Association, now recommend that most patients can continue taking GLP-1 receptor agonists before elective surgeries. This change is based on research indicating that stopping these medications does not significantly reduce the risk of aspiration during anesthesia, which was a primary concern due to the drugs' effects on gastric emptying. Patients are advised to follow a clear liquid diet for 24 hours prior to surgery to minimize potential risks. Furthermore, ongoing studies indicate that while GLP-1 usage prior to bariatric surgery is safe, it does not enhance weight loss compared to surgery alone. The guidance emphasizes the importance of individual risk assessment and collaboration with healthcare teams to ensure patient safety. Overall, the updated recommendations reflect a shift towards a more nuanced understanding of the risks and benefits associated with GLP-1 medications in the perioperative period.